New Cholesterol Pill Drops Bad Cholesterol 60% | Business and Finance News

FDA just approved Lipfendra, the first oral PCSK9 inhibitor that slashes LDL cholesterol by nearly 60% in just six months—better than some statins and even usable with them. Merck’s new drug could prevent heart attacks and strokes, with trials ongoing. Priced at $10.50 per pill ($315/month), it’s cheaper than injectables but still steep for many. Expected to hit shelves soon, with Medicare and payment plans helping those without insurance. High cholesterol? Silent killer—get tested. New tool. Big cost debate. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/14070398601a23fc